(TheNewswire)
Vancouver, B.C. / TheNewswire / February 17, 2017 – UMBRAL ENERGY CORP. (CSE: UMB)
(the “Company” or “Umbral”) announces, that it has granted a total of 2,200,000 incentive stock options to
directors/officers/employees and/or consultants under the Company’s Stock Option Plan. The options are exercisable at $0.09 per
share and will expire February 17, 2022. Following this grant of options, the Company has 6,500,000 stock options
outstanding.
About Umbral Energy Corp.
The Company is currently listed as a junior resource issuer having mineral exploration projects. The Company is
considering other activities to increase shareholder value, including non-resource projects.
The Company has mineral exploration projects in Utah, Nevada and Quebec. In addition the Company has an interest in
PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana.
ON BEHALF OF THE BOARD OF DIRECTORS OF UMBRAL ENERGY CORP.
“Jag Bal”
Jagdip Bal President and CEO
NEITHER CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and
other factors that may cause actual events to differ materially from current expectation. Important factors - including the
availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results
to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the
date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Copyright (c) 2017 TheNewswire - All rights reserved.